Limits on the Role of Community Pharmacists in Reducing Use of Antipsychotics for BPSD: Qualitative Research (BMJ Open)


An investigation into the factors, constraints and potential barriers which might limit the ability of community pharmacists to contribute to the limitation of antipsychotics use in the treatment of behavioural and psychological symptoms of dementia (BPSD) identifies:

  1. Politics and the medical hierarchy, resulting in communication barriers.
  2. The impact resources and remit on the effectiveness of community pharmacies
  3. Understanding the nature of dementia and its treatment.

Full Text Link


Maidment, ID. Aston, L. [and] Hilton, A. [et al] (2016). Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): a qualitative study. BMJ Open, 2016, Vol.6(3), e010278. (Click here to view the PubMed abstract).

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Antipsychotics, Community Care, For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, NHS, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.